{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:03:18Z","timestamp":1778817798007,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ejso.2020.01.020","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T11:32:49Z","timestamp":1579260769000},"page":"607-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"PA","title":["Cost analysis of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and the risk factors for their increased cost in a public insurance health care system \u2013 Single centre study"],"prefix":"10.1016","volume":"46","author":[{"given":"Du\u0161an","family":"Klos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juraj","family":"Ri\u0161ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominika","family":"Kriv\u00e1\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Love\u010dek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Skalick\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u010cestm\u00edr","family":"Neoral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohuslav","family":"Melichar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Moheln\u00edkov\u00e1-Ducho\u0148ov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radmila","family":"Lemstrov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejso.2020.01.020_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2020.01.020_bib2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ctrv.2006.11.001","article-title":"Pseudomyxoma peritonei","volume":"33","author":"Smeenk","year":"2007","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"10.1016\/j.ejso.2020.01.020_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jso.21055","article-title":"Consensus statement on peritoneal mesothelioma","volume":"98","author":"Deraco","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.01.020_bib4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2020.01.020_bib5","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","article-title":"Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy","volume":"17","author":"Glehen","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.01.020_bib6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ejso.2020.01.020_bib7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.anchir.2005.05.013","article-title":"Cost of an intraperitoneal chemohyperthermia (IPCH) releated to cytoreductive surgery","volume":"130","author":"Bonastre","year":"2005","journal-title":"Ann Chir"},{"issue":"4","key":"10.1016\/j.ejso.2020.01.020_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.soc.2012.07.011","article-title":"The importance of the learning curve and surveillance of surgical performance in peritoneal surface malignancy programs","volume":"21","author":"Kusamura","year":"2012","journal-title":"Surg Oncol Clin N Am"},{"issue":"6","key":"10.1016\/j.ejso.2020.01.020_bib9","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","article-title":"Should be treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic r","volume":"249","author":"Chua","year":"2009","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.ejso.2020.01.020_bib10","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1586\/14737140.8.11.1809","article-title":"Intraperitoneal hyperthermic chemotherapy: an evolving paradigm for the treatment of peritoneal surface malignancies","volume":"8","author":"Stewart","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"10.1016\/j.ejso.2020.01.020_bib11","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2020.01.020_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"2","key":"10.1016\/j.ejso.2020.01.020_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2020.01.020_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2020.01.020_bib15","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00268-019-04950-y","article-title":"Prehabilitation before major abdominal surgery: a systematic review and meta-analysis","volume":"43","author":"Hughes","year":"2019","journal-title":"World J Surg"},{"issue":"11","key":"10.1016\/j.ejso.2020.01.020_bib16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00104-010-1927-1","article-title":"Hypertherme intraperitoneale Chemotherapie im G-DRG-System","volume":"81","author":"Kilian","year":"2010","journal-title":"Chirurg"},{"issue":"3","key":"10.1016\/j.ejso.2020.01.020_bib17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ejso.2014.12.004","article-title":"Peritonectomy and hyperthermic intraperitoneal chemotherapy: cost analysis and sustainability","volume":"41","author":"Bagnoli","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.01.020_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejso.2010.03.005","article-title":"Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"36","author":"Baratti","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.01.020_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/SLA.0b013e3181c9b53c","article-title":"Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancies program","volume":"251","author":"Chua","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2020.01.020_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/836425","article-title":"Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution in Japan","volume":"2012","author":"Mizumoto","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.ejso.2020.01.020_bib21","article-title":"Gastrointestinal complications in 147 consecutive patients with peritoneal surface malignancy treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy","volume":"2011","author":"Casado-Adam","year":"2011","journal-title":"Int J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.01.020_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/ejso.2001.1152","article-title":"Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma","volume":"28","author":"Begossi","year":"2002","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.01.020_bib23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1245\/ASO.2006.03.079","article-title":"Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy","volume":"13","author":"Sugarbaker","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2020.01.020_bib24","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320300214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320300214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:31:48Z","timestamp":1760059908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320300214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0748798320300214"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.01.020","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost analysis of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and the risk factors for their increased cost in a public insurance health care system \u2013 Single centre study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}